Pan Pharmaceuticals on the Way to Recovery

1 October 2003--Australia's medicines watchdog, the Therapeutic Goods Administration (TGA) today confirmed that its recent audit of the Pan Pharmaceuticals plant in Sydney found a satisfactory level of compliance with Good Manufacturing Practice requirements for the production of soft gel capsule products.

The company, which is in being administered by a liquidator/administrator, has indicated it will now apply formally for a licence reinstatement with conditions to restrict manufacture to low risk soft gel capsules such as herbals, vitamins and minerals.

Pending the company meeting the appropriate fit and proper person test, the TGA may be in a position to lift the licence suspension over the next week.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.